|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000172890 |
Summary for NADSYN1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000172890 | Gene symbol | NADSYN1 |
| Gene name | NAD synthetase 1 | |
| HGNC | 29832 | |
| Entrez ID | 55191 | |
| Gene type | protein_coding | |
| Synonyms | NADSYN1|FLJ10631 | |
| UniProtAcc | Q6IA69 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000172890 | NADSYN1 | DB00142 | Glutamic acid | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for NADSYN1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for NADSYN1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for NADSYN1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| CHOL | cg01630362 | chr11:71452482 | CGI:chr11:71453051-71453634 | promoter | 2.80e-01 | 1.51e-01 | 2.99e+00 | 2.77e-03 | 8.11e-03 | 1.29e-01 |
| CHOL | cg20728496 | chr11:71452509 | CGI:chr11:71453051-71453634 | promoter | 3.07e-01 | 1.20e-01 | 3.25e+00 | 1.17e-03 | 4.25e-03 | 1.87e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg05963690 | chr11:71452420 | CGI:chr11:71453051-71453634 | promoter | 2.23e-01 | 8.27e-02 | 3.24e+00 | 1.19e-03 | 2.92e-03 | 1.40e-01 |
| LUSC | cg04774822 | chr11:71454793 | CGI:chr11:71453051-71453634 | promoter,gene body | 6.08e-01 | 8.47e-01 | -4.29e+00 | 1.78e-05 | 5.26e-04 | -2.39e-01 |
| BLCA | cg05963690 | chr11:71452420 | CGI:chr11:71453051-71453634 | promoter | 1.81e-01 | 3.13e-01 | -3.85e+00 | 1.18e-04 | 4.51e-04 | -1.33e-01 |
| BLCA | cg01630362 | chr11:71452482 | CGI:chr11:71453051-71453634 | promoter | 1.58e-01 | 2.82e-01 | -3.22e+00 | 1.30e-03 | 2.78e-03 | -1.24e-01 |
| BLCA | cg04774822 | chr11:71454793 | CGI:chr11:71453051-71453634 | promoter,gene body | 5.23e-01 | 6.74e-01 | -2.07e+00 | 3.89e-02 | 4.11e-02 | -1.50e-01 |
| ESCA | cg05963690 | chr11:71452420 | CGI:chr11:71453051-71453634 | promoter | 2.58e-01 | 7.26e-02 | 2.54e+00 | 1.10e-02 | 3.67e-02 | 1.85e-01 |
| ESCA | cg01630362 | chr11:71452482 | CGI:chr11:71453051-71453634 | promoter | 2.91e-01 | 9.74e-02 | 2.51e+00 | 1.20e-02 | 3.70e-02 | 1.94e-01 |
| ESCA | cg20728496 | chr11:71452509 | CGI:chr11:71453051-71453634 | promoter | 1.93e-01 | 7.37e-02 | 2.20e+00 | 2.75e-02 | 4.30e-02 | 1.19e-01 |
| CHOL | cg04774822 | chr11:71454793 | CGI:chr11:71453051-71453634 | promoter,gene body | 6.99e-01 | 8.43e-01 | -2.43e+00 | 1.50e-02 | 2.65e-02 | -1.44e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRP | cg04774822 | chr11:71454793 | CGI:chr11:71453051-71453634 | promoter,gene body | 6.29e-01 | 5.06e-01 | 2.01e+00 | 4.44e-02 | 4.60e-02 | 1.23e-01 |
Top |
Exon skipping events with PSI in TCGA for NADSYN1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for NADSYN1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for NADSYN1 |
TFs related to NADSYN1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
NADSYN1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for NADSYN1 |
RBPs related to ES in NADSYN1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | SRSF2 | exon_skip_62891 | 8.85e+00 | 1.02e-02 | 9.15e+00 | 9.86e-01 | Female-biased |
| THYM | RBM28 | exon_skip_62930 | 1.25e+01 | 9.97e-01 | 1.21e+01 | 2.23e-03 | Male-biased |
| LIHC | SRSF2 | exon_skip_62891 | 9.15e+00 | 9.89e-01 | 8.72e+00 | 7.04e-03 | Male-biased |
| COAD | RBM28 | exon_skip_62930 | 1.20e+01 | 8.09e-03 | 1.24e+01 | 9.91e-01 | Female-biased |
| DLBC | SRSF2 | exon_skip_62891 | 9.17e+00 | 9.85e-01 | 8.84e+00 | 1.08e-02 | Male-biased |
| THCA | ESRP2 | exon_skip_62935 | 8.68e+00 | 9.94e-01 | 8.14e+00 | 3.58e-04 | Male-biased |
| THCA | RBM28 | exon_skip_62930 | 1.23e+01 | 9.99e-01 | 1.18e+01 | 5.66e-04 | Male-biased |
| MESO | RBM28 | exon_skip_62930 | 1.19e+01 | 1.08e-03 | 1.25e+01 | 9.98e-01 | Female-biased |
| GBM | RBM28 | exon_skip_62930 | 1.19e+01 | 1.93e-03 | 1.23e+01 | 9.98e-01 | Female-biased |
| PAAD | RBM28 | exon_skip_62930 | 1.21e+01 | 4.30e-03 | 1.25e+01 | 9.95e-01 | Female-biased |
| KIRC | RBM28 | exon_skip_62930 | 1.18e+01 | 1.75e-03 | 1.23e+01 | 9.98e-01 | Female-biased |
| KICH | RBM28 | exon_skip_62930 | 1.24e+01 | 9.97e-01 | 1.19e+01 | 2.29e-03 | Male-biased |
NADSYN1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73505309 | chr11:80442967:G:T | - | 0.204474789797013 | 0.0116888851437741 | HNSC | Female-baised eQTL |
| rs12787393 | chr11:73447245:C:A | - | 0.166923532959299 | 0.0355613841639245 | HNSC | Female-baised eQTL |
| rs751690 | chr11:70761880:G:A | - | 0.130448033483109 | 0.0461446273638805 | SARC | Female-baised eQTL |
| rs201241533 | chr11:68926283:T:A | - | 0.131159861931929 | 0.00118052817650964 | LUSC | Female-baised eQTL |
| rs79808713 | chr11:68949393:G:A | - | 0.123034611355179 | 0.00257852406682225 | LUSC | Female-baised eQTL |
| rs4435007 | chr11:68974418:C:T | - | 0.117809185759072 | 0.00357690664185849 | LUSC | Female-baised eQTL |
| rs77450978 | chr11:68970456:T:C | - | 0.114619680976565 | 0.00624918970378546 | LUSC | Female-baised eQTL |
| rs17421328 | chr11:70017223:C:T | - | 0.105807767403803 | 0.00920035306634665 | LUSC | Female-baised eQTL |
| rs11232442 | chr11:81038668:T:G | - | 0.15285859664134 | 0.011189185646991 | STAD | Female-baised eQTL |
| rs3915314 | chr11:62229378:A:G | - | 0.109417306610764 | 0.0121624710804949 | STAD | Female-baised eQTL |
| rs11605184 | chr11:70885792:G:A | - | 0.142693776371341 | 0.0173242760285715 | STAD | Female-baised eQTL |
| rs1498326 | chr11:81017610:C:T | - | 0.162048607659002 | 0.0327403980382841 | STAD | Female-baised eQTL |
| rs17203005 | chr11:70651357:C:T | - | 0.230888980313307 | 0.00101920061484444 | BLCA | Female-baised eQTL |
| rs3019849 | chr11:70838998:C:G | - | -0.061921481379388 | 0.0400537114007981 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4486655 | chr11:81203800:T:G | - | 0.190040122023745 | 0.0153421749407737 | PCPG | Male-baised eQTL |
| rs2729751 | chr11:77388928:G:A | - | 0.213204221073711 | 0.0381224713648251 | PCPG | Male-baised eQTL |
| rs10736785 | chr11:72007866:C:A | - | -0.0599893570070415 | 0.0138687394234884 | LIHC | Male-baised eQTL |
| rs7121260 | chr11:71989520:G:A | - | -0.0540724925428135 | 0.0315848459413564 | LIHC | Male-baised eQTL |
| rs1892919 | chr11:72001129:G:A | - | -0.0550461660502285 | 0.0322875494877645 | LIHC | Male-baised eQTL |
| rs2845857 | chr11:72004169:C:G | - | -0.0534773081844611 | 0.0438428430830939 | LIHC | Male-baised eQTL |
| rs1573500 | chr11:72021744:C:G | - | -0.0510082512446487 | 0.0479894568527744 | LIHC | Male-baised eQTL |
| rs4109879 | chr11:63057692:G:A | - | -0.0730352107727133 | 0.0197291969918037 | LGG | Male-baised eQTL |
| rs7926184 | chr11:63069875:T:G | - | -0.0741162815915617 | 0.0202650291279765 | LGG | Male-baised eQTL |
| rs116873148 | chr11:62146788:G:A | - | 0.0589734443459255 | 3.83968237216113e-05 | BLCA | Male-baised eQTL |
| rs11605129 | chr11:69283448:C:T | - | 0.0704393137733924 | 0.000922427362270326 | BLCA | Male-baised eQTL |
| rs11607320 | chr11:69286538:G:A | - | 0.0678767209797901 | 0.00111351787470983 | BLCA | Male-baised eQTL |
| rs67808136 | chr11:69287584:G:A | - | 0.067678929833471 | 0.00118900010138726 | BLCA | Male-baised eQTL |
| rs11230718 | chr11:61498702:A:C | - | 0.053065845426281 | 0.00302361796663567 | BLCA | Male-baised eQTL |
| rs7123102 | chr11:72131257:T:A | - | 0.0645206998878278 | 0.0041413887847545 | BLCA | Male-baised eQTL |
| rs11605162 | chr11:69283400:G:A | - | 0.0623036643070324 | 0.00438879282845652 | BLCA | Male-baised eQTL |
| rs11607762 | chr11:69283578:T:A | - | 0.0578210719611451 | 0.00772573080801962 | BLCA | Male-baised eQTL |
| rs11606885 | chr11:69286439:C:T | - | 0.0583613274628433 | 0.00819619168399039 | BLCA | Male-baised eQTL |
| rs751984 | chr11:61510774:T:C | - | 0.0429166799025308 | 0.014589202455837 | BLCA | Male-baised eQTL |
| rs12224901 | chr11:81195259:T:C | - | 0.0497373312052032 | 0.0224573536380262 | BLCA | Male-baised eQTL |
| rs12223533 | chr11:81195260:G:A | - | 0.0497373312052032 | 0.0224573536380262 | BLCA | Male-baised eQTL |
| rs61884100 | chr11:79446308:C:G | - | 0.0612104070033561 | 0.0224828628039771 | BLCA | Male-baised eQTL |
| rs7128974 | chr11:71965986:C:G | - | -0.0539899636171171 | 0.0246836516925688 | BLCA | Male-baised eQTL |
| rs71462309 | chr11:62475815:G:A | - | -0.0501164468246703 | 0.0256989332501574 | BLCA | Male-baised eQTL |
| rs74511143 | chr11:62475819:C:G | - | -0.0501164468246703 | 0.0256989332501574 | BLCA | Male-baised eQTL |
| rs75971473 | chr11:62475820:G:T | - | -0.0501164468246703 | 0.0256989332501574 | BLCA | Male-baised eQTL |
| rs55966956 | chr11:62475827:G:A | - | -0.0501164468246703 | 0.0256989332501574 | BLCA | Male-baised eQTL |
| rs56104217 | chr11:62475831:C:G | - | -0.0501164468246703 | 0.0256989332501574 | BLCA | Male-baised eQTL |
| rs10897165 | chr11:61510413:G:A | - | 0.040868688989724 | 0.0259308367775266 | BLCA | Male-baised eQTL |
| rs675485 | chr11:62477600:G:A | - | -0.0493784516511166 | 0.0267880489603251 | BLCA | Male-baised eQTL |
| rs11230728 | chr11:61510226:A:G | - | 0.0407044840154246 | 0.027302871767812 | BLCA | Male-baised eQTL |
| rs10897768 | chr11:81214504:A:G | - | 0.0427010141867393 | 0.0331088005048204 | BLCA | Male-baised eQTL |
| rs11232532 | chr11:81216341:A:G | - | 0.0427010141867393 | 0.0331088005048204 | BLCA | Male-baised eQTL |
| rs7125196 | chr11:61505093:T:C | - | 0.0384248105611818 | 0.0362694028665962 | BLCA | Male-baised eQTL |
| rs10897164 | chr11:61510303:A:G | - | 0.0395332338341395 | 0.0368386914279772 | BLCA | Male-baised eQTL |
| rs55853432 | chr11:79451574:A:T | - | 0.0593385486111998 | 0.0426406381289015 | BLCA | Male-baised eQTL |
| rs11263639 | chr11:69387835:A:G | - | 0.0398766324067478 | 0.0433810299363546 | BLCA | Male-baised eQTL |
| rs7102185 | chr11:69411078:C:T | - | -0.0278280189584719 | 0.0440839286837766 | BLCA | Male-baised eQTL |
| rs7942690 | chr11:69056472:T:C | - | -0.0519528108000384 | 0.0443848523980581 | BLCA | Male-baised eQTL |
| rs174565 | chr11:61824164:C:G | - | 0.0333623625144141 | 0.0458381930179365 | BLCA | Male-baised eQTL |
| rs519796 | chr11:64977672:A:C | - | -0.0347564178387071 | 0.0475903484746353 | BLCA | Male-baised eQTL |
| rs11605184 | chr11:70885792:G:A | - | 0.092705453128345 | 0.0265783639778839 | LUAD | Male-baised eQTL |
| rs3019758 | chr11:69123317:T:C | - | 0.134777901801165 | 0.00550904354217072 | COAD | Male-baised eQTL |
| rs11234014 | chr11:71521765:G:A | gene | -0.0685433881686548 | 0.00576498445297295 | COAD | Male-baised eQTL |
| rs7925616 | chr11:79508801:A:C | - | 0.130845473786811 | 0.00992769493365569 | COAD | Male-baised eQTL |
| rs56928493 | chr11:69122031:G:A | - | 0.131876795630749 | 0.0145938690634249 | COAD | Male-baised eQTL |
| rs4930444 | chr11:67575109:G:A | - | 0.0606488535862025 | 0.0150356581841813 | COAD | Male-baised eQTL |
| rs239254 | chr11:65219178:C:T | - | -0.0634965437168367 | 0.0174710319850303 | COAD | Male-baised eQTL |
| rs239255 | chr11:65219657:G:A | - | -0.0634965437168367 | 0.0174710319850303 | COAD | Male-baised eQTL |
| rs239256 | chr11:65219920:C:T | - | -0.0634965437168367 | 0.0174710319850303 | COAD | Male-baised eQTL |
| rs2514482 | chr11:81278396:G:A | - | -0.0608506716733597 | 0.0192922759998355 | COAD | Male-baised eQTL |
| rs2904978 | chr11:65233007:C:T | - | -0.064309860354902 | 0.0199034682913782 | COAD | Male-baised eQTL |
| rs58753751 | chr11:72337769:T:C | - | 0.122365917799627 | 0.0205642263256331 | COAD | Male-baised eQTL |
| rs77331289 | chr11:72338512:G:A | - | 0.122365917799627 | 0.0205642263256331 | COAD | Male-baised eQTL |
| rs73528892 | chr11:72309100:G:C | - | 0.118205787425685 | 0.022167320669256 | COAD | Male-baised eQTL |
| rs239253 | chr11:65217272:C:T | - | -0.0620330245372677 | 0.0224638195189696 | COAD | Male-baised eQTL |
| rs11333544 | chr11:71507868:T:A | gene | -0.0613600703014127 | 0.02323355345579 | COAD | Male-baised eQTL |
| rs2186777 | chr11:71508757:C:A | gene | -0.0613600703014127 | 0.02323355345579 | COAD | Male-baised eQTL |
| rs7925331 | chr11:71514896:A:G | gene | -0.0607482263459446 | 0.0255326872609194 | COAD | Male-baised eQTL |
| rs2373711 | chr11:80997655:C:T | - | 0.0699501708526154 | 0.0259811392687123 | COAD | Male-baised eQTL |
| rs79326857 | chr11:71512210:C:T | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs148838851 | chr11:71512996:G:A | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs7938023 | chr11:71514803:G:A | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs201177618 | chr11:71516515:G:A | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs111835395 | chr11:71516683:A:T | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs7118246 | chr11:71520078:G:C | gene | -0.0605094398762078 | 0.0261755108888966 | COAD | Male-baised eQTL |
| rs3892955 | chr11:69822897:G:A | - | 0.0609094253599076 | 0.0267680077598741 | COAD | Male-baised eQTL |
| rs1945491 | chr11:71417204:C:A | - | -0.0582080354191747 | 0.0273127769505162 | COAD | Male-baised eQTL |
| rs1379728 | chr11:81279053:T:C | - | -0.0592082512534951 | 0.0274082621315456 | COAD | Male-baised eQTL |
| rs2513087 | chr11:65224767:G:A | - | -0.0622389151013507 | 0.0274411567748749 | COAD | Male-baised eQTL |
| rs529915 | chr11:63960535:C:T | - | -0.0565518721284522 | 0.0315578720337647 | COAD | Male-baised eQTL |
| rs1783964 | chr11:63962009:G:A | - | 0.0565518721284522 | 0.0315578720337647 | COAD | Male-baised eQTL |
| rs3019782 | chr11:63963325:A:G | - | 0.0565518721284522 | 0.0315578720337647 | COAD | Male-baised eQTL |
| rs1386346 | chr11:63955809:G:A | - | -0.056760993746 | 0.0320924736422891 | COAD | Male-baised eQTL |
| rs7127705 | chr11:73288019:C:T | - | -0.0732518701635859 | 0.0324364965952738 | COAD | Male-baised eQTL |
| rs7127013 | chr11:73288176:G:A | - | -0.0732518701635859 | 0.0324364965952738 | COAD | Male-baised eQTL |
| rs7932510 | chr11:79231703:T:A | - | 0.0958539460628894 | 0.0333004473336803 | COAD | Male-baised eQTL |
| rs6592175 | chr11:71514551:G:C | gene | -0.0596000404744083 | 0.0348936802091986 | COAD | Male-baised eQTL |
| rs4245442 | chr11:71509863:T:C | gene | -0.0596084112114137 | 0.0352999362025441 | COAD | Male-baised eQTL |
| rs7926180 | chr11:71511139:C:T | gene | -0.0596084112114137 | 0.0352999362025441 | COAD | Male-baised eQTL |
| rs7944274 | chr11:71511568:T:C | gene | -0.0596084112114137 | 0.0352999362025441 | COAD | Male-baised eQTL |
| rs146615255 | chr11:71512367:C:T | gene | -0.0596084112114137 | 0.0352999362025441 | COAD | Male-baised eQTL |
| rs12808183 | chr11:71517071:A:G | gene | -0.0596084112114137 | 0.0352999362025441 | COAD | Male-baised eQTL |
| rs650834 | chr11:72289233:C:A | - | 0.10729796031041 | 0.0376546051564964 | COAD | Male-baised eQTL |
| rs2508204 | chr11:72290776:T:C | - | 0.10729796031041 | 0.0376546051564964 | COAD | Male-baised eQTL |
| rs590732 | chr11:72295350:C:T | - | 0.10729796031041 | 0.0376546051564964 | COAD | Male-baised eQTL |
| rs1784257 | chr11:72296940:T:C | - | 0.10729796031041 | 0.0376546051564964 | COAD | Male-baised eQTL |
| rs1789172 | chr11:69679824:C:T | - | -0.0540543191343597 | 0.0401519993899106 | COAD | Male-baised eQTL |
| rs7938498 | chr11:63962318:A:G | - | 0.0559792918860555 | 0.0408274719626107 | COAD | Male-baised eQTL |
| rs7105151 | chr11:71406273:G:A | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs1540128 | chr11:71407142:G:A | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs4944043 | chr11:71407779:G:C | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs7114296 | chr11:71407957:C:T | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs4944045 | chr11:71410046:G:T | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs4944046 | chr11:71412748:C:G | - | -0.0546699299761796 | 0.0422025051547727 | COAD | Male-baised eQTL |
| rs3892954 | chr11:69822995:A:G | - | 0.0592031041462367 | 0.042203266174286 | COAD | Male-baised eQTL |
| rs472837 | chr11:72296106:C:T | - | 0.105619876164073 | 0.0431190991414616 | COAD | Male-baised eQTL |
| rs1566240 | chr11:81007340:T:C | - | -0.0543385717275529 | 0.0433961976169955 | COAD | Male-baised eQTL |
| rs11231646 | chr11:63935163:T:C | - | -0.0540643143946951 | 0.0476335156289825 | COAD | Male-baised eQTL |
| rs55680030 | chr11:79230960:G:T | - | 0.10235059505524 | 0.0477123600242161 | COAD | Male-baised eQTL |
| rs4426138 | chr11:63967791:T:C | - | 0.0537826569535132 | 0.0488474160180449 | COAD | Male-baised eQTL |
| rs578295 | chr11:63969148:G:A | - | 0.0537826569535132 | 0.0488474160180449 | COAD | Male-baised eQTL |
| rs533420 | chr11:65215807:C:A | - | -0.0534115160125903 | 0.0488815011520336 | COAD | Male-baised eQTL |
| rs10792680 | chr11:71405506:C:T | - | -0.0538338606534074 | 0.0490170187520708 | COAD | Male-baised eQTL |
| rs10898091 | chr11:71405984:C:T | - | -0.0538338606534074 | 0.0490170187520708 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg04774822 | chr11:71454793 | gene,promoter | -0.449493709741732 | 2.66562475213676e-44 | -0.8107246857481534 | 3.708016425256392e-48 | KIRP |
| cg11291531 | chr11:71518942 | gene | -0.449493709741732 | 2.66562475213676e-44 | -0.8107246857481534 | 3.708016425256392e-48 | KIRP |
| cg04665565 | chr11:71519688 | gene | -0.449493709741732 | 2.66562475213676e-44 | -0.8107246857481534 | 3.708016425256392e-48 | KIRP |
| cg04665565 | chr11:71519688 | gene | -0.158707973993256 | 3.5072549709882e-12 | -0.4429553299440404 | 4.345110602602747e-16 | BLCA |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs79326857 | chr11:71512210:C:T | Distant downstream | 0.0296011611470802 | 0.021516659158953 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs1540129 | chr11:71418477:G:C | Distant upstream | 0.0289727775237018 | 0.02322698939479 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs11333544 | chr11:71507868:T:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs2186777 | chr11:71508757:C:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs148838851 | chr11:71512996:G:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs7938023 | chr11:71514803:G:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs201177618 | chr11:71516515:G:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs111835395 | chr11:71516683:A:T | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs7118246 | chr11:71520078:G:C | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs11234014 | chr11:71521765:G:A | Distant downstream | 0.0287522643106338 | 0.0258990327053796 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs7925331 | chr11:71514896:A:G | Distant downstream | 0.0282532047376849 | 0.0352881269524182 | LIHC | Female-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs11236569 | chr11:70532867:G:A | Distant upstream | -0.0323878141369895 | 0.0353096984150232 | LIHC | Female-baised sQTL |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs510925 | chr11:72098454:C:T | Distant downstream | -0.027172560063964 | 0.0340381159226481 | LIHC | Male-baised sQTL |
| exon_skip_62924 | chr11:71481355:71481404 | Frame-shift | rs2250866 | chr11:72093467:G:A | Distant downstream | -0.0240029312171204 | 0.0360165333598079 | LIHC | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of NADSYN1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |